Don't miss the next edition! Sign up to our newsletter and automatically receive our quarterly wrap-ups, insights & news 📨Welcome to the OracleBio Q2 2023 Wrap-Up. In this edition, we wrap up all our highlights from the previous 3 months. There's a lot to cover,...
.
Q1 (2023) Wrap-Up: Insights, Blogs, Trending Content & more
Don't miss the next edition! Sign up to our newsletter and automatically receive our quarterly wrap-ups, insights & news 📨Welcome to the OracleBio Q1 2023 Wrap-Up. In this edition, we wrap up all our highlights from the previous 3 months. There's a lot to cover,...
Q3 (2022) Wrap-Up: Insights, Blogs, Trending Content & more
Don't miss the next edition! Sign up to our newsletter and automatically receive our quarterly wrap-ups, insights & news 📨Welcome to the OracleBio Q3 2022 Wrap-Up. In this edition, we wrap up all our highlights from the previous 3 months. There's a lot to cover,...
OracleBio’s work published in ‘ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma’ paper
Keep your finger on the pulse. Sign up for our newsletter and automatically receive our latest research, insights & news 📨We are delighted to see this collaborative study being published! The paper, 'ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma:...
Q2 (2022) Wrap-Up: Insights, Blogs, Trending Content & more
Don't miss the next edition! Sign up to our newsletter and automatically receive our quarterly wrap-ups, insights & news 📨Welcome to the OracleBio Q2 2022 Wrap-Up. In this edition, we wrap up all our highlights from the previous 3 months. There's a lot to cover,...
Alida Buchan joins OracleBio as HR Business Partner
We're delighted to welcome Alida Buchan to the OracleBio team! As our new HR Business Partner, Alida brings fresh thinking and a wealth of experience — having previously supported the growth ambitions and development of the people behind innovative SMEs through to...
Q1 (2022) Wrap-up: Insights, Blogs, Trending Content & more
Welcome to the OracleBio Q1 2022 Wrap Up! In this edition, we wrap up all of our latest news and insights from Jan-March. There's a lot to cover, so grab a tea or coffee ☕TRENDING BLOG Using Deep Learning to address Staining Variance across Multiplex IF images...
Lorcan Sherry panel discussion at Ultivue’s Digital Insights to Tumor Biology event
OracleBio Chief Scientific Officer, Lorcan Sherry, was invited to be part of Ultivue's interactive panel for their virtual event, 'Digital Insights to Tumor Biology: Uncovering the Complexities of the Tumor Immune Microenvironment with Digital Pathology'. Lorcan...
OracleBio launch GCP Image Analysis Services
We are proud to announce the launch of OracleBio's GCP Image Analysis Services. This latest service offering strengthens the company’s position as a global leader in quantitative digital pathology, expanding the company’s foothold in the clinical market. Our new...
Dr Gabriele Kohnen Joins OracleBio as Senior Clinical Pathologist
OracleBio is pleased to welcome Dr Gabriele Kohnen to the team as Senior Clinical Pathologist. Gabriele is a Consultant Clinical Pathologist with 25 years experience in Diagnostic Healthcare. She has specialist expertise in liver, gastrointestinal tract, placenta and...
Ultivue and OracleBio Partner to help Advance Personalized Tumor Characterization and Clinical Oncology Research
OracleBio and Ultivue have announced a collaborative partnership to help further insights and advance personalized tumor characterization in translational and clinical oncology research and drug development using multiplex immunofluorescence staining and imaging. The...
OracleBio integrates Indica Labs HALO AI™ to enhance Digital Pathology Software Capabilities
OracleBio continues to enhance its digital pathology software capabilities by integrating Indica Labs HALO AI™ into its image analysis workflow. This latest step in OracleBio’s development will enable the quantitative digital pathology services provider to meet...